Dow Up 1.32% Nasdaq Up 1.60%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
54.13 3.46(6.83%) Oct 23, 4:00PM EDT
Prev Close:50.67
Open:51.79
Bid:49.50 x 200
Ask:54.46 x 200
1y Target Est:84.80
Beta:1.56
Next Earnings Date:27-Oct-14LGND Earnings announcement
Day's Range:51.69 - 54.82
52wk Range:41.99 - 80.42
Volume:496,468
Avg Vol (3m):432,754
Market Cap:1.12B
P/E (ttm):149.94
EPS (ttm):0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LGNDUp 6.83%1.12B
LLY68.96B
MRK163.36B
RHHBY249.03B

Key Statistics

Forward P/E (1 yr):22.55
P/S (ttm):19.39
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.54
Quarterly EPS Est (Sep-14) :0.31
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.17

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback